New Antituberculous Drugs in Development
Author:
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Virology
Link
http://link.springer.com/content/pdf/10.1007/s11904-010-0054-4.pdf
Reference72 articles.
1. •• Lalloo UG, Pillay S: Managing tuberculosis and HIV in sub-Sahara Africa. Curr HIV/AIDS Rep 2008, 5:132–139. This is a recommended review outlining the challenges related to TB and HIV in sub-Saharan Africa.
2. Lalloo UG, Naidoo R, Ambaram A: Recent advances in the medical and surgical treatment of multi-drug resistant tuberculosis. Curr Opin Pulm Med 2006, 3:179–185.
3. • Gandhi NR, Shah NS, Andrews JR, et al.; Tugela Ferry Care and Research (TF CARES) Collaboration: HIV coinfection in multidrug- and extensively drug-resistant tuberculosis results in high early mortality. Am J Respir Crit Care Med 2010, 181:80–86. These are current data showing high mortality from drug-resistant TB in a rural setting.
4. Chambers HF, Turner J, Schecter GF, et al.: Imipenem for treatment of tuberculosis in mice and humans. Antimicrob Agents Chemother 2005, 49:2816–2821.
5. Chambers HF, Kocagoz T, Sipit T, et al.: Activity of amoxicillin/clavulanate in patients with tuberculosis. Clin Infect Dis 1998, 26:874–877.
Cited by 42 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Polymeric Nanoparticles in Tuberculosis;Tubercular Drug Delivery Systems;2023
2. Studies in Development and Statistical Optimization of Levofloxacin Solid Lipid Nanoparticles for the Treatment of Tuberculosis;Journal of Pharmaceutical Innovation;2022-01-19
3. Nano-based drug delivery optimization for tuberculosis treatment: A review;Journal of Microbiological Methods;2021-02
4. Approaches toward designing nanocarriers for tuberculosis drug delivery;A Mechanistic Approach to Medicines for Tuberculosis Nanotherapy;2021
5. Pulmonary Delivery of Linezolid Nanoparticles for Treatment of Tuberculosis: Design, Development, and Optimization;Journal of Pharmaceutical Innovation;2020-09-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3